Actinium Pharmaceuticals, Inc. (ATNM)
1.41
+0.01
(+0.71%)
USD |
NYAM |
Dec 09, 12:51
Actinium Pharmaceuticals Total Liabilities (Quarterly): 42.37M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arcus Biosciences, Inc. | 538.00M |
| Apyx Medical Corp. | 51.28M |
| AbbVie, Inc. | 136.50B |
| Karyopharm Therapeutics, Inc. | 365.49M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.15M |
| Shareholders Equity (Quarterly) | 13.78M |
| Debt to Equity Ratio | 0.0829 |
| Current Ratio | 7.955 |
| Net Debt Paydown Yield | 0.28% |